---
$id: https://graph.org.ai/products/commodity/51281817
$type: Product
source: UNSPSC
code: "51281817"
title: "Doxorubicin aglycone"
class: "51281800"
classTitle: "Anthracyclines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doxorubicin aglycone

**UNSPSC Code**: 51281817
**Class**: [Anthracyclines](Anthracyclines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a doxorubicin preparation with the molecular formula C21H18O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X023T6C35L, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8s,10s)-, but more generally known as doxorubicin aglycone, which bears US NIH Compound Identifier 72401. European Medicines Agency schedules doxorubicin aglycone or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06391MIG. Most nations, for tariff purposes, schedule doxorubicin aglycone under HS 29419000. SMILES: COC1CCCC2C1C(=O)C3C(C(C4C(C3O)[C@H](C[C@@](C4)(C(=O)CO)O)O)O)C2=O.

